International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: https://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2024, 12(1), 1-11
DOI: 10.12691/ijcd-12-1-1
Open AccessReview Article

Toward an Etiology of Celiac Disease

Simon H Williams1,

1Independent researcher

Pub. Date: December 22, 2024

Cite this paper:
Simon H Williams. Toward an Etiology of Celiac Disease. International Journal of Celiac Disease. 2024; 12(1):1-11. doi: 10.12691/ijcd-12-1-1

Abstract

The review proposes a model of the etiology of celiac disease. It describes how an enteroviral attack by a lytic virus leads to hyper-extracellular Transglutaminase 2, Tg2, evident at all stages of the disease by the presence of anti-tTG. The demand for Tg2 is supplied by both the cell and the lytic virus. The demand leads to excess Tg2 passing through the cell wall, excess ingress of Ca2+, the destruction of the mitochondria by Ca2+, and pyroptosis of the cell. The increase in extracellular Tg2 during the cell's life and following pyroptosis has two effects. First, it binds a C1r inhibitor to the vascular wall, preventing C1r-LP from converting prehaptoglobin (zonulin) into haptoglobin, causing the weakening of the tight junctions among the epithelial cells and allowing the entry of extraneous luminal materials and particularly the access of Tg2 arterial and luminal, as it is now open directly to the lumen and the mesenchyme structure. It is this Tg2 that damages the villus structure as the Tg2 binds fibronectin into the mesenchyme, causing scarring, shrinkage, and turning the villi into the rigid scarred structures characteristic of CD. The model suggests why CD is a chronic lifelong disease reactivated upon the resumption of gluten consumption. A discussion of Non-Celiac Gluten Sensitivity and Refractory CD follows. The paper explains how extracellular transglutaminase causes zonulin and damages the extracellular membrane. Thus, zonulin is a symptom, not a cause. Notably, the paper demonstrates that the basic tenet of autoimmune diseases, that the cells destroy themselves, is incorrect, at least for CD. Applying this etiology to other conditions may be relevant because of the almost universal glutaminolysis in cells and the substantial amount of Gluten in modern diets.

Keywords:
Celiac Non-Celiac Gluten Sensitivity NCGS Refractory Coxsackie virus Transglutaminase Gluten Villus Apoptosis Pyroptosis

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Gujral N, Freeman HJ, Thomson AB. Celiac disease: Prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol WJG [Internet]. 2012 Nov 14 [cited 2022 Oct 8]; 18(42): 6036–59. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/ PMC3496881/.
 
[2]  Oikarinen M, Puustinen L, Lehtonen J, Hakola L, Simell S, Toppari J, et al. Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study. Front Immunol [Internet]. 2021 [cited 2022 May 4]; 11. Available from: https://www.frontiersin.org/article/10.3389/fimmu.2020.604529.
 
[3]  Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, et al. Presence of anti-‘tissue’ transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ [Internet]. 2001 Jul [cited 2022 Feb 15]; 8(7): 767–70. Available from: https:// www.nature.com/ articles/4400880.
 
[4]  Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Hankaniemi MM, Huhtala H, et al. Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes. Diabetes [Internet]. 2014 Jan 16 [cited 2022 Feb 5]; 63(2): 446–55.
 
[5]  Dechaumes A, Bertin A, Sane F, Levet S, Varghese J, Charvet B, et al. Coxsackievirus-B4 Infection Can Induce the Expression of Human Endogenous Retrovirus W in Primary Cells. Microorganisms. 2020 Sep 1; 8(9):E1335.
 
[6]  Cohn A, Sofia AM, Kupfer SS. Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis. Curr Diab Rep. 2014 Aug; 14(8): 517.
 
[7]  Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, et al. In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of Monocytes. PLoS Med [Internet]. 2006 Sep [cited 2023 Apr 28]; 3(9): e358. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569884/.
 
[8]  Kahrs CR, Chuda K, Tapia G, Stene LC, Mårild K, Rasmussen T, et al. Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ [Internet]. 2019 Feb 13 [cited 2022 Oct 22]; 364: l231. Available from: https://www.bmj.com/content/364/bmj.l231.
 
[9]  Lindfors K, Lin J, Lee HS, Hyöty H, Nykter M, Kurppa K, et al. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut [Internet]. 2020 Aug [cited 2022 Oct 22];69(8):1416–22. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/PMC7234892/.
 
[10]  Mayer KA, Stöckl J, Zlabinger GJ, Gualdoni GA. Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction. Front Immunol [Internet]. 2019 [cited 2022 May 9]; 10. Available from: https:// www.frontiersin.org/ article/ 10.3389/ fimmu.2019.01533.
 
[11]  Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro. J Virol [Internet]. 2002 May [cited 2023 Jan 29]; 76(9): 4430–40. Available from: https:// www. ncbi.nlm.nih.gov/ pmc/ articles/PMC155066/.
 
[12]  Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R. Recent Progress in Understanding Coxsackievirus Replication, Dissemination, and Pathogenesis. Virology [Internet]. 2015 Oct [cited 2022 Oct 6]; 484: 288–304. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567421/.
 
[13]  Cox JE, Sullivan CS. Balance and Stealth: The Role of Noncoding RNAs in the Regulation of Virus Gene Expression. Annu Rev Virol [Internet]. 2014 Nov 3 [cited 2023 Jan 29]; 1(1): 89–109.
 
[14]  Feuer R, Whitton JL. Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr Top Microbiol Immunol. 2008; 323: 149–73.
 
[15]  Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, et al. Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period. J Virol [Internet]. 2009 Sep [cited 2023 Feb 6]; 83(18):9356–69. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/ PMC2738251/.
 
[16]  Hana Hien Le, Valeriia Dotsenko, Amirbabak Sioofy Khojine, Jutta Laiho, Heikki Hyöty, Keijo Viiri,. Modelling enterovirus-induced predisposition to celiac disease: single-cell transcriptomic analysis of coxsackie B virus-infected organoids. Celiac Disease Research Center, Faculty of Medicine and Health Technology Tampere Finland. In: Personal Communication. Sheffield UK; 2024.
 
[17]  Sarmiento L, Galvan J, Cabrera-Rode E, Aira L, Correa C, Sariego Frometa S, et al. Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections. J Med Virol. 2012 Jul 1; 84: 1049–53.
 
[18]  Goga A, Yagabasan B, Herrmanns K, Godbersen S, Silva PN, Denzler R, et al. miR-802 regulates Paneth cell function and enterocyte differentiation in the mouse small intestine. Nat Commun [Internet]. 2021 Jun 7 [cited 2023 Feb 5];12(1):3339. Available from: https://www.nature.com/articles/s41467-021-23298-3.
 
[19]  Cheng ML, Chien KY, Lai CH, Li GJ, Lin JF, Ho HY. Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection. Cells. 2020 Feb 18; 9(2): E473.
 
[20]  Pasquali CC, Islam Z, Adamoski D, Ferreira IM, Righeto RD, Bettini J, et al. The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats. J Biol Chem [Internet]. 2017 Jul 7 [cited 2022 May 26]; 292(27): 11572–85. Available from: https://www.jbc.org/article/S0021-9258(20) 37023-X/abstract.
 
[21]  Hirabara SM, Gorjao R, Levada-Pires AC, Masi LN, Hatanaka E, Cury-Boaventura MF, et al. Host cell glutamine metabolism as a potential antiviral target. Clin Sci [Internet]. 2021 Jan 22 [cited 2022 May 4]; 135(2): 305–25.
 
[22]  VOOIJS M, LIU Z, KOPAN R. Notch: Architect, Landscaper, and Guardian of the Intestine. Gastroenterology [Internet]. 2011 Aug [cited 2020 Nov 14]; 41(2): 448–59. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050496/.
 
[23]  Montgomery RK, Carlone DL, Richmond CA, Farilla L, Kranendonk MEG, Henderson DE, et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A [Internet]. 2011 Jan 4 [cited 2022 May 15]; 08(1): 179–84. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017192/.
 
[24]  Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of Mammalian microRNA Host Genes and Transcription Units. Genome Res [Internet]. 2004 Jan 10 [cited 2023 Feb 12]; 14(10a):1902–10. Available from: https://genome.cshlp.org/content/14/10a/1902.
 
[25]  Stanger BZ, Datar R, Murtaugh LC, Melton DA. Direct regulation of intestinal fate by Notch. Proc Natl Acad Sci [Internet]. 2005 Aug 30 [cited 2021 Jan 1]; 102(35): 12443–8. Available from: https://www.pnas.org/content/102/35/12443.
 
[26]  Sander GR, Powell BC. Expression of Notch Receptors and Ligands in the Adult Gut. J Histochem Cytochem [Internet]. 2004 Apr 1 [cited 2021 Aug 20]; 52(4): 509–16.
 
[27]  Zecchini V. Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev [Internet]. 2005 Jul 15 [cited 2021 Jan 1]; 19(14): 1686–91.
 
[28]  Drummond CG, Bolock AM, Ma C, Luke CJ, Good M, Coyne CB. Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc Natl Acad Sci U S A. 2017 Feb 14; 114(7): 1672–7.
 
[29]  Günther C, Ruder B, Stolzer I, Dorner H, He GW, Chiriac MT, et al. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn’s Disease. Gastroenterology. 2019 Nov; 157(5): 1310-1322.e13.
 
[30]  Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007 Oct 25; 449(7165): 1003–7.
 
[31]  Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008 Jul; 40(7): 915–20.
 
[32]  Wieser H, Koehler P, Scherf KA. Chemistry of wheat gluten proteins: Qualitative composition. Cereal Chem [Internet]. 2023 [cited 2023 Jun 22]; 100(1): 23–35.
 
[33]  33.Mitea C, Kooy-Winkelaar Y, van Veelen P, de Ru A, Drijfhout JW, Koning F, et al. Fine specificity of monoclonal antibodies against celiac disease–inducing peptides in the gluteome. Am J Clin Nutr [Internet]. 2008 Oct 1 [cited 2020 Apr 8]; 88(4): 1057–66. Available from: https:// academic.oup.com/ ajcn/article/88/4/1057/4650029.
 
[34]  Silberberg M. The Molecular Nature of Matter and change. 5th ed. McGraw-Hill; 2008.
 
[35]  Bhutia YD, Ganapathy V. Glutamine transporters in mammalian cells and their functions in physiology and cancer. Biochim Biophys Acta BBA - Mol Cell Res [Internet]. 2016 Oct 1 [cited 2021 Jun 12]; 1863(10): 2531–9. Available from: https:// www.sciencedirect.com/science/article/pii/S0167488915004383.
 
[36]  Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A [Internet]. 2004 Mar 23 [cited 2022 Sep 23];101(12):4175–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC384714/.
 
[37]  Kunji ERS, Aleksandrova A, King MS, Majd H, Ashton VL, Cerson E, et al. The transport mechanism of the mitochondrial ADP/ATP carrier. Biochim Biophys Acta BBA - Mol Cell Res [Internet]. 2016 Oct 1 [cited 2022 Apr 26];1863(10):2379–93. Available from: https:// www.sciencedirect.com/ science/ article/pii/S0167488916300684.
 
[38]  Morotomi‐Yano K, Yano K. Calcium‐dependent activation of transglutaminase 2 by nanosecond pulsed electric fields. FEBS Open Bio [Internet]. 2017 Jun 9 [cited 2022 Feb 10];7(7):934–43. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC5494297/.
 
[39]  Wang Z, Perez M, Lee ES, Kojima S, Griffin M. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial–mesenchymal transition. Cell Death Dis [Internet]. 2017 Sep [cited 2022 Jun 4]; 8(9):e3032–e3032. Available from: https:// www.nature.com/articles/cddis2017399.
 
[40]  Sevinc E. NIVELES DE AMINOÁCIDOS EN NIÑOS CON ENFERMEDAD CELÍACA. Nutr Hosp [Internet]. 2015 Jul 1 [cited 2020 Jan 31];(1):139–43.
 
[41]  Thangaratnarajah C, Ruprecht JJ, Kunji ERS. Calcium-induced conformational changes of the regulatory domain of human mitochondrial aspartate/glutamate carriers. Nat Commun. 2014 Nov 20; 5: 5491.
 
[42]  del Arco A, Contreras L, Pardo B, Satrustegui J. Calcium regulation of mitochondrial carriers. Biochim Biophys Acta BBA - Mol Cell Res [Internet]. 2016 Oct 1 [cited 2022 Apr 26];1863(10):2413–21. Available from: https:// www.sciencedirect.com/ science/ article/pii/S0167488916300775.
 
[43]  Biasutto L, Azzolini M, Szabò I, Zoratti M. The mitochondrial permeability transition pore in AD 2016: An update. Biochim Biophys Acta BBA - Mol Cell Res [Internet]. 2016 Oct 1 [cited 2022 Apr 26]; 1863(10): 2515–30. Available from: https:// www.sciencedirect.com/ science/article/pii/S0167488916300349.
 
[44]  Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature. 2009 Apr 30;458(7242):1127–30.
 
[45]  Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol. 2004 Jan;24(1):200–16.
 
[46]  Perez F, Ruera CN, Miculan E, Carasi P, Chirdo FG. Programmed Cell Death in the Small Intestine: Implications for the Pathogenesis of Celiac Disease. Int J Mol Sci [Internet]. 2021 Jul 10 [cited 2022 Sep 29];22(14):7426. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306608/.
 
[47]  H P Rang, J M Ritter, R.J.Flower, G.Henderson. Chapter 40 Neurodegenerative diseases Excitoxicity and Apoptosis. In: Pharmacology. 2012th ed. Elsevier.
 
[48]  Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatol Baltim Md. 1995 May;21(5):1465–8.
 
[49]  Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setty M, Bhagat G, et al. Reprogramming of CTLs into natural killer–like cells in celiac disease. J Exp Med [Internet]. 2006 May 15 [cited 2022 Oct 17];203(5):1343–55. Available from: https:// www. ncbi.nlm.nih.gov/ pmc/ articles/PMC2121214//
 
[50]  Barbaro M, Cremon C, Caio G, De Giorgio R, Volta U, Stanghellini V, et al. Zonulin serum levels are increased in non-celiac gluten sensitivity and irritable bowel syndrome. 2015 [cited 2020 Jul 3]; 27: 5–5. Available from: https:// iris.unife.it/handle/ 11392/2407752#.Xv8KAyV7lyU.
 
[51]  Singh P, Silvester J, Chen X, Xu H, Sawhney V, Rangan V, et al. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D. United Eur Gastroenterol J [Internet]. 2019 Jun [cited 2020 Jun 28];7(5):709–15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545708/.
 
[52]  Fasano A. Regulation of Intercellular Tight Junctions by Zonula Occludens Toxin and Its Eukaryotic Analogue Zonulin. Ann N Y Acad Sci [Internet]. 2000 [cited 2020 Jun 28]; 915(1):214–22.
 
[53]  A T, Km L, S G, T SD, S NA, Ms B, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A [Internet]. 2009 Sep 15 [cited 2020 Jun 28];106(39):16799–804. Available from: https://europepmc.org/article/med/19805376.
 
[54]  Wicher KB, Fries E. Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein. Proc Natl Acad Sci [Internet]. 2004 Oct 5 [cited 2019 Dec 18];101(40):14390–5.
 
[55]  Ligoudistianou C, Xu Y, Garnier G, Circolo A, Volanakis JE. A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s. Biochem J [Internet]. 2005 Apr 1 [cited 2020 Jul 20]; 387(Pt 1):165–73. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1134944/.
 
[56]  Davis AE, Mejia P, Lu F. BIOLOGICAL ACTIVITIES OF C1 INHIBITOR. Mol Immunol [Internet]. 2008 Oct [cited 2022 Mar 2];45(16):4057–63. Available from: https:// www.ncbi.nlm.nih.gov /pmc/articles/PMC2626406/
 
[57]  C1 Inhibitor Cross-linking by Tissue Transglutaminase* - Journal of Biological Chemistry [Internet]. [cited 2022 Mar 2]. Available from: https://www.jbc.org/article/S0021-9258(19)80634-8/fulltext.
 
[58]  Rossi V, Bally I, Ancelet S, Xu Y, Frémeaux-Bacchi V, Vives R, et al. Functional Characterization of the Recombinant Human C1 Inhibitor Serpin Domain: Insights into Heparin Binding. J Immunol Baltim Md 1950. 2010 Mar 1;184:4982–9.
 
[59]  Dardik R, Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): Proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res [Internet]. 2006 Oct 1 [cited 2022 Jun 7];312(16):2973–82. Available from: https:// www.sciencedirect.com/science/article/pii/S0014482706001947.
 
[60]  Nagy Szakál D, Győrffy H, Arató A, Cseh Á, Molnár K, Papp M, et al. Mucosal expression of claudins 2, 3 and 4 in proximal and distal part of duodenum in children with coeliac disease. Virchows Arch [Internet]. 2010 Mar 1 [cited 2020 Jun 28];456(3):245–50.
 
[61]  Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. Mesenchymal Cells of the Intestinal Lamina Propria. Annu Rev Physiol [Internet]. 2011 [cited 2022 Feb 13];73:213–37. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754809/.
 
[62]  Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol. 1990 Jun;116(2):177–84.
 
[63]  Ensari A, Marsh MN. Exploring the villus. Gastroenterol Hepatol Bed Bench [Internet]. 2018 [cited 2021 Aug 10];11(3):181–90. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/PMC6040026/.
 
[64]  Huachun Cui, Na Xie, Dingyuan Jiang, Sami Banerjee, Jing Ge, Yan Y. Sanders, et al. Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis. Am J Respir Cell Mol Biol [Internet]. 2019 Oct [cited 2022 Jun 4];Volume 61(Number 4):8.
 
[65]  Tatsukawa H, Furutani Y, Hitomi K, Kojima S. Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis [Internet]. 2016 Jun [cited 2022 Oct 7];7(6):e2244–e2244. Available from: https://www.nature.com/articles/cddis2016150.
 
[66]  Wang Z, Collighan RJ, Gross SR, Danen EHJ, Orend G, Telci D, et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling. J Biol Chem [Internet]. 2010 Dec 1 [cited 2022 Aug 14];285(51):40212–29. Available from: https:// europepmc.org/ articles/PMC3001003.
 
[67]  Wang Z, Collighan RJ, Pytel K, Rathbone DL, Li X, Griffin M. Characterization of Heparin-binding Site of Tissue Transglutaminase. J Biol Chem [Internet]. 2012 Apr 13 [cited 2022 Jun 10];287(16):13063–83. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339925/.
 
[68]  Borggrefe T, Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci CMLS. 2009 May;66(10):1631–46.
 
[69]  Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature [Internet]. 2005 Jun [cited 2022 Feb 18];435(7044):964–8. Available from: https:// www.nature.com/ articles/nature03589.
 
[70]  Basak NP, Roy A, Banerjee S. Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway. J Biol Chem [Internet]. 2014 Mar 14 [cited 2020 May 15];289(11):7320–34. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC3953249/.
 
[71]  Basak NP, Banerjee S. Crosstalk between Notch signaling Pathway and Glutamine uptake during Jurkat T cell activation. Matters [Internet]. 2016 Feb 19 [cited 2020 May 15];2(2):e201602000030. Available from: https:// sciencematters.io/ articles/201602000030.
 
[72]  Kai Y. Intestinal villus structure contributes to even shedding of epithelial cells. Biophys J [Internet]. 2021 Feb 16 [cited 2023 May 5];120(4):699–710. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC7896031/.
 
[73]  Yang H, Wang X, Xiong X, Yin Y. Energy metabolism in intestinal epithelial cells during maturation along the crypt-villus axis. Sci Rep [Internet]. 2016 Aug 25 [cited 2022 Aug 14];6:31917. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC4997266/.
 
[74]  Williams JM, Duckworth CA, Burkitt MD, Watson AJM, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 2015 May;52(3):445–55.
 
[75]  Jores RD, Frau F, Cucca F, Grazia Clemente M, Orrù S, Rais M, et al. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand J Gastroenterol. 2007 Jan;42(1):48–53.
 
[76]  Yi MC, Melkonian AV, Ousey JA, Khosla C. Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2. J Biol Chem. 2018 Feb 23;293(8):2640–9.
 
[77]  Wang M, Dong Q, Wang H, He Y, Chen Y, Zhang H, et al. Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57. Oncotarget [Internet]. 2016 Feb 1 [cited 2022 Jun 9];7(8):8797–808. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/PMC4891005/.
 
[78]  Staudacher HM, Irving PM, Lomer MCE, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol [Internet]. 2014 Apr [cited 2025 Jul 13];11(4):256–66. Available from: https:// www.nature.com/ articles/nrgastro.2013.259.
 
[79]  Non-Celiac Gluten Sensitivity. In: Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods [Internet]. 1st ed. OmniaScience; 2015 [cited 2025 Jul 11]. p. 441–62. Available from: https:// www.omniascience.com/ books/index.php/monographs/catalog/book/83.
 
[80]  Aziz I, Lewis NR, Hadjivassiliou M, Winfield SN, Rugg N, Kelsall A, et al. A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. Eur J Gastroenterol Hepatol [Internet]. 2014 Jan [cited 2025 Jul 13];26(1):33. Available from: https://journals.lww.com/eurojgh/abstract/2014/01000/a_uk_study_assessing_the_population_prevalence_of.6.aspx.
 
[81]  Biesiekierski JR, Newnham ED, Shepherd SJ, Muir JG, Gibson PR. Characterization of Adults With a Self-Diagnosis of Nonceliac Gluten Sensitivity. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2014 Aug;29(4):504–9.
 
[82]  Bajor J, Szakács Z, Farkas N, Hegyi P, Illés A, Solymár M, et al. Classical celiac disease is more frequent with a double dose of HLA-DQB1*02: A systematic review with meta-analysis. PLoS ONE [Internet]. 2019 Feb 14 [cited 2023 May 27];14(2):e0212329. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/ articles/PMC6375622/.
 
[83]  Lenders C, Liu S, Wilmore D, Sampson L, Dougherty L, Spiegelman D, et al. Evaluation of a novel food composition database that includes glutamine and other amino acids derived from gene sequencing data. Eur J Clin Nutr [Internet]. 2009 Dec [cited 2020 Feb 16];63(12):1433–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249386/.
 
[84]  Xue K, MacLaren RE. Correcting visual loss by genetics and prosthetics. Curr Opin Physiol [Internet]. 2020 Aug [cited 2023 May 3];16:1–7. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC7115840/.
 
[85]  Crane R, Conley SM, Al-Ubaidi MR, Naash MI. Gene Therapy to the Retina and the Cochlea. Front Neurosci [Internet]. 2021 [cited 2023 May 3];15. Available from: https:// www.frontiersin.org/ articles/10.3389/fnins.2021.652215.
 
[86]  Basak NP, Roy A, Banerjee S. Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway. J Biol Chem [Internet]. 2014 Mar 14 [cited 2020 May 15];289(11):7320–34. Available from: https:// www.ncbi.nlm.nih.gov/ pmc/articles/PMC3953249/.